Extremely potent immunotherapeutic activity of a STING agonist in the B16 melanoma model in vivo

Documenti analoghi

• The STING pathway and the T cell-inflamed tumor microenvironment
  di: Woo, Seng-Ryong, et al.
  Pubblicazione: (2015)
• Innate immune sensing of a growing tumor in vivo occurs via the host sting pathway and involves mitochondrial DNA transfer from cancer cells to DCs
  di: Woo, Seng-Ryong, et al.
  Pubblicazione: (2013)
• Evidence implicating the commensal microbiota in shaping anti-tumor immunity in melanoma
  di: Sivan, Ayelet, et al.
  Pubblicazione: (2014)
• Antagonism of the STING pathway via activation of the AIM2 inflammasome by intracellular DNA
  di: Corrales, Leticia, et al.
  Pubblicazione: (2016)
• Direct activation of STING in the tumor microenvironment with synthetic cyclic dinucleotide derivatives leads to potent and systemic tumor-specific immunity
  di: Corrales, Leticia, et al.
  Pubblicazione: (2014)